Yahoo Finance Site Map
ArticlesFor a comprehensive guide to our content, please see the Site Index
SiteMap 2016 > 11 > 25
Other dates of the month:
- British wage growth looks 'dreadful' after Brexit - IFS
- J&J makes takeover approach for Swiss drugmaker Actelion: Bloomberg
- Xiaomi says shrinking smartphone sales won't hit the company
- BRIEF-Cab Cakaran Corporation updates on proposed acquisition by unit
- BRIEF-MKH posts qtrly net profit 50.4 million rgt
- GLOBAL MARKETS-Global equities climb, dollar on back foot
- Want to Eat Healthier During the Holidays? Watch Out for These 10 Types of Loopholes.
- Trump Can’t Make America Great If He Kicks the Medicare Can Down the Road
- Apple's one-day shopping event is today and it's offering free gift cards up to $150
- Turkey's fight against coup plotters to continue "for some time"-dep PM
- Airbus hopes to deliver up to 80 A350 aircraft in 2017 -sources
- SE Asia Stocks-Most rise on local buying; foreign investors away
- Australian banks admit to Malaysia currency 'cartel', pay fines
- BRIEF-Hibiscus Petroleum qtrly net profit 80.3 mln RGT
- EMERGING MARKETS-Retreating dollar gives emerging markets a breather
- European shares head for 3rd week of gains, Actelion leads
- Cutting tool maker Sandvik looks to software, 3D printing to stay ahead
- Semperit says dispute with Thai unit hurting glove business, expansion
- Apple's one-day shopping event is today, and the company is offering free gift cards up to $150
- Indian cash crunch hits gold demand during peak wedding season
- INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Impax Laboratories Inc. and Encourages Investors with Losses to Contact the Firm
- IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Centene Corp. and Encourages Investors with Losses to Contact the Firm
- MONDAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Reminds Investors with Losses to Contact the Firm
- Ontario SCPA reduces cat adoption fees on Black Friday to find forever families for homeless cats
- IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Arrowhead Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
- IMPORTANT EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alere Inc. and Encourages Investors with Losses to Contact the Firm
- Buyer Beware: Layaway Plans Can Have Added Costs
- BRIEF-Time Dotcom qtrly net profit 55.4 million rgt
- BRIEF-Southern steel says Danieli co commenced arbitration proceedings against Southern Hrc Sdn
- Sterling heads for best run of gains vs euro since early 2015
- BRIEF-Sunway posts qtrly net profit 143.6 million rgt
- Bull of the Day: Copa (CPA)
- Digital the future for French banks says central bank boss
- BRIEF-MQ Technology appoints Edwin Silvester Das as executive director
- Japan plans supercomputer to leap into technology future
- Kenyan ride-hailing app Little may expand into Nigeria or Uganda
- Developers Bring Home the Gold in the South East Asia Property Awards 2016 Finale
- More puts sold in Oasis Petroleum
- Russneft IPO demand exceeds offer by over 30 percent - co-owner
- China probes Chongqing Iron and Steel Group executive over 'discipline breach'
- As Trump promises to 'cancel job-killing' energy red tape, US renewables grow
- Here's one sign that ad blocking's meteoric growth could start to slow down
- China gold premiums hit near 3-year high; India premiums drop on subdued demand
- BRIEF-Knusford bhd updates on material litigation
- Bear of the Day: The Andersons (ANDE)
- BRIEF-Chin Teck Plantations re-designates Gan Kok Tiong as Chief Financial Officer
- BRIEF-Ikhmas Jaya Group updates on letter of award from TTDI KL Metropolis
- Electrovaya to Present at the Barclays Energy Revolution and Exane BNP Paribas' Disruptive Tech Investor's Conferences
- New Strong Sell Stocks for November 25th
- Is The Mateon Therapeutics Inc (NASDAQ:MATN) Delisting A Discount Op?